Follow-Up Study of Patients Previously Treated With Pimecrolimus Tablets for Atopic Dermatitis

Extension Study to Assess Safety and Efficacy of Pimecrolimus in Adult Patients With Atopic Dermatitis

NCT00232011 ·Status: COMPLETED ·Phase: PHASE3

Extension Study of Pimecrolimus Cream in Pediatric Patients With Atopic Dermatitis

NCT00231998 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Pimecrolimus Cream 1% in Patients (2 to 11 Years Old) With Mild to Moderate Facial Atopic Dermatitis

NCT00130364 ·Status: COMPLETED ·Phase: PHASE4

Combination Therapy for Atopic Dermatitis

NCT00119158 ·Status: COMPLETED ·Phase: PHASE4

Open-label Study to Investigate Systemic Exposure in Adult and Pediatric Atopic Dermatitis Patients Treated 8.5 Days With Pimecrolimus Cream 1% Under Occlusion

NCT00925730 ·Status: COMPLETED ·Phase: PHASE4

Study Comparing Product 0405 to a Vehicle Control in the Treatment of Mild to Moderate Atopic Dermatitis in Pediatric Subjects

NCT02176551 ·Status: WITHDRAWN ·Phase: PHASE3

A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis

NCT05995964 ·Status: RECRUITING ·Phase: PHASE2

A Study Evaluating the Safety and Efficacy of QGE031 in Atopic Dermatitis Patients

NCT01552629 ·Status: COMPLETED ·Phase: PHASE2

Effects of Pimecrolimus Cream 1% on the Molecular and Cellular Profile of Adult Male Patients With Atopic Dermatitis

NCT00117377 ·Status: COMPLETED ·Phase: PHASE4

A Long-Term Extension Trial in Participants With Atopic Dermatitis Who Participated in Previous EDP1815 Trials

NCT05439941 ·Status: TERMINATED ·Phase: PHASE2

A Quality of Life and Safety Study With Pimecrolimus Cream, 1% in Children (Age 2-12 Years) With Atopic Dermatitis

NCT00484003 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis

NCT02087943 ·Status: COMPLETED ·Phase: PHASE2

Pimecrolimus and Epidermal Barrier Function

NCT01132079 ·Status: COMPLETED ·Phase: NA

A Single-center, Randomized, Double-blinded, Placebo-controlled, Phase 1 Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of NCP112

NCT05638165 ·Status: COMPLETED ·Phase: PHASE1

Open Label Study of Long Term Treatment of Pediatric Treatment of Atopic Dermatitis With Pimecrolimus Cream 1% Within a Usual Clinical Setting

NCT00509990 ·Status: COMPLETED ·Phase: PHASE4

10 Year Registry of Children (Ages 2-17 Years) With Eczema That Have Used Pimecrolimus

NCT00568997 ·Status: ACTIVE_NOT_RECRUITING

Pharmacokinetics (PK), Safety, Efficacy and Maximal Use PK of ARQ-151 in Adolescents/Children With Mild/Moderate Eczema

NCT04156191 ·Status: COMPLETED ·Phase: PHASE1

Open Label Extension Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis

NCT04804605 ·Status: COMPLETED ·Phase: PHASE3

A Study Investigating the Effect of EDP1815 in the Treatment of Mild, Moderate and Severe Atopic Dermatitis

NCT05121480 ·Status: COMPLETED ·Phase: PHASE2

A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Moderate to Severe Atopic Dermatitis

NCT03747575 ·Status: COMPLETED ·Phase: PHASE2

Effects of Pimecrolimus on Skin Biopsy Ex-plants From Patients With Atopic Dermatitis

NCT00379678 ·Status: COMPLETED

Safety and Efficacy of ARQ-151 Cream in Adolescents and Adults With Atopic Dermatitis

NCT03916081 ·Status: COMPLETED ·Phase: PHASE2

5-Year Safety Study of Pimecrolimus Cream 1% in Infants 3 - 12 Months of Age With Mild to Moderate Atopic Dermatitis

NCT00120523 ·Status: COMPLETED ·Phase: PHASE3

Study of 0416 Ointment in the Treatment of Atopic Dermatitis

NCT01053247 ·Status: COMPLETED ·Phase: PHASE3

Study of Pimecrolimus Treatment for Atopic Dermatitis of African American Children

NCT00810862 ·Status: TERMINATED ·Phase: PHASE4